These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16755176)

  • 1. Concurrent chemoradiotherapy with doxifluridine and paclitaxel for extrahepatic bile duct cancer.
    Park JY; Park SW; Chung JB; Seong J; Kim KS; Lee WJ; Song SY
    Am J Clin Oncol; 2006 Jun; 29(3):240-5. PubMed ID: 16755176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative chemoradiotherapy for extrahepatic bile duct cancer.
    Park JH; Choi EK; Ahn SD; Lee SW; Song SY; Yoon SM; Kim YS; Lee YS; Lee SG; Hwang S; Lee YJ; Park KM; Kim TW; Chang HM; Lee JL; Kim JH
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):696-704. PubMed ID: 20510541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer.
    Kim SW; Noh OK; Kim JH; Chun M; Oh YT; Kang SY; Lee HW; Park RW; Yoon D
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1161-1167. PubMed ID: 28447209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH; Bao Y; Chen M; Zhang L; Li KX; Xu GC; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2006 Oct; 25(10):1279-83. PubMed ID: 17059776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial.
    Schoppmeyer K; Miethe S; Wiedmann M; Liebmann A; Hauss J; Mossner J; Caca K; Witzigmann H; Hildebrandt G
    Am J Clin Oncol; 2006 Dec; 29(6):576-82. PubMed ID: 17148994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage radiotherapy for locoregionally recurrent extrahepatic bile duct cancer after radical surgery.
    Kim E; Kim YJ; Kim K; Song C; Kim JS; Oh DY; Nam EM; Chie EK
    Br J Radiol; 2017 Dec; 90(1080):20170308. PubMed ID: 28937265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trial.
    Nishimura R; Tominaga T; Kimura M; Yanagita Y; Tamaki N; Asaishi K; Okamoto Y; Okuyama N; Takeuchi H; Inaba M; Doi T
    Anticancer Drugs; 2008 Oct; 19(9):911-5. PubMed ID: 18766005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
    Wang J; Pang QS; Wang P; Wang J; Wang W
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):769-72. PubMed ID: 18396691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy and razoxane in advanced bile duct carcinomas.
    Rhomberg W; Stephan H; Böhler F; Erhart K; Eiter H
    Anticancer Res; 2005; 25(5):3613-8. PubMed ID: 16101189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer.
    Nomura M; Yamakado K; Nomoto Y; Nakatsuka A; Ii N; Shoji K; Takeda K
    Int J Oncol; 2002 Feb; 20(2):325-31. PubMed ID: 11788896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
    Deodato F; Clemente G; Mattiucci GC; Macchia G; Costamagna G; Giuliante F; Smaniotto D; Luzi S; Valentini V; Mutignani M; Nuzzo G; Cellini N; Morganti AG
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):483-8. PubMed ID: 16242254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
    Takiuchi H; Goto M; Imamura H; Furukawa H; Imano M; Imamoto H; Kimura Y; Ishida H; Fujitani K; Narahara H; Shimokawa T
    Jpn J Clin Oncol; 2008 Mar; 38(3):176-81. PubMed ID: 18281707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery.
    Park HJ; Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Anticancer Res; 2014 Nov; 34(11):6685-90. PubMed ID: 25368275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Prognostic Factors and the Efficacy of Adjuvant S-1 Chemotherapy in Patients with Post-surgery Extrahepatic Bile Duct Cancer.
    Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Sui K; Shimada Y; Iiyama T
    Anticancer Res; 2017 Dec; 37(12):7049-7056. PubMed ID: 29187494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
    Montemaggi P; Morganti AG; Dobelbower RR; Brizi G; Smaniotto D; Costamagna G; Cellini N; Marano P
    Radiology; 1996 Jun; 199(3):861-6. PubMed ID: 8638018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma.
    Matsumoto S; Kiyosue H; Komatsu E; Wakisaka M; Tomonari K; Hori Y; Matsumoto A; Mori H
    Cancer; 2004 Jun; 100(11):2422-9. PubMed ID: 15160347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.
    Kim MW; Kim WH; Wang HJ; Chung JB; Chun M
    Hepatogastroenterology; 2001; 48(41):1298-301. PubMed ID: 11677950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.